Homogeneous time-resolved fluorescence assay for identifying p53 interactions with its protein partners, directly in a cellular extract

Analytical Biochemistry

Volumn 308, Issue 2, 2002, Pages 247-254

  Leblanc, Virginie ^a   Delaunay, Valérie ^b   Claude Lelong, Jean ^a   Gas, Fabienne ^c   Mathis, Gérard ^d   Grassi, Jacques ^b   May, Evelyne ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^b DIF   (France)

^c CEA VALRHO Centre de Marcoule   (France)

^d CIS Bio International   (France)

Author keywords

Europium cryptate; FRET; HTRF; Immunoassay; P53; Protein interaction; SV40 LTag; TRACE

Indexed keywords

ASSOCIATION REACTIONS; DIAGNOSIS; ENERGY TRANSFER; FLUORESCENCE; MONOCLONAL ANTIBODIES; TUMORS;

FRET; HTRF; IMMUNOASSAY; PROTEIN INTERACTION; SV40-LTAG; TRACE;

DRUG INTERACTIONS;

ALLOPHYCOCYANIN; CELL EXTRACT; CELL PROTEIN; EPITOPE; EUROPIUM; MONOCLONAL ANTIBODY; PROTEIN; PROTEIN P53; VIRUS PROTEIN;

ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DNA DAMAGE; DRUG SCREENING; ENERGY TRANSFER; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; IMMUNOASSAY; PRIORITY JOURNAL; TECHNOLOGY; VALIDATION PROCESS;

EID: 0037108991     PISSN: 00032697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-2697(02)00229-4     Document Type: Article

References (36)

1. P. May, E. May, Twenty years of p53 research: structural and functional aspects of the p53 protein, Oncogene 18 (1999) 7621-7636.
2. C. Prives, P.A. Hall, The p53 pathway, J. Pathol. 187 (1999) 112-126.
3. A.J. Giaccia, M.B. Kastan, The complexity of p53 modulation: emerging patterns from divergent signals, Genes Dev. 12 (1998) 2973-2983.
4. E. Appella, C.W. Anderson, Signaling to p53: breaking the posttranslational modification code, Pathol. Biol. 48 (2000) 227-245.
5. Y. Liu, A.L. Colosimo, X.J. Yang, D. Liao, Adenovirus E1B 55-kilodalton oncoprotein inhibits p53 acetylation by PCAF, Mol. Cell Biol. 20 (2000) 5540-5553.
6. C.J. Thut, J.A. Goodrich, R. Tjian, Repression of p53-mediated transcription by MDM2: a dual mechanism, Genes Dev. 11 (1997) 1974-1986.
7. H.M. Sheppard, S.I. Corneillie, C. Espiritu, A. Gatti, X. Liu, New insights into the mechanism of inhibition of p53 by simian virus 40 large T antigen, Mol. Cell Biol. 19 (1999) 2746-2753.
8. A.R. Cuddihy, A.H. Wong, N.W. Tam, S. Li, A.E. Koromilas, The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro, Oncogene 18 (1999) 2690-2702.
9. P. Wagner, A. Fuchs, C. Gotz, W. Nastainczyk, M. Montenarh, Fine mapping and regulation of the association of p53 with p34cdc2, Oncogene 16 (1998) 105-111.
10. T. Unger, R.V. Sionov, E. Moallem, C.L. Yee, P.M. Howley, M. Oren, Y. Haupt, Mutations in serines 15 and 20 of human p53 impair its apoptotic activity, Oncogene 18 (1999) 3205-3212.
11. N.H. Chehab, A. Malikzay, M. Appel, T.D. Halazonetis, Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53, Genes Dev. 14 (2000) 278-288.
12. A. Hirao, Y.Y. Kong, S. Matsuoka, A. Wakeham, J. Ruland, H. Yoshida, D. Liu, S.J. Elledge, T.W. Mak, DNA damage-induced activation of p53 by the checkpoint kinase Chk2, Science 287 (2000) 1824-1827.
13. K. Sakaguchi, S. Saito, Y. Higashimoto, S. Roy, C.W. Anderson, E. Appella, Damage-mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a casein 1-like kinase-Effect on Mdm2 binding, J. Biol. Chem. 275 (2000) 9278-9283.
14. P.F. Lambert, F. Kashanchi, M.F. Radonovich, R. Shiekhattar, J.N. Brady, Phosphorylation of p53 serine 15 increases interaction with CBP, J. Biol. Chem. 273 (1998) 33048-33053.
15. M.J. Waterman, E.S. Stavridi, J.L. Waterman, T.D. Halazonetis, ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins, Nature Genet. 19 (1998) 175-178.
16. M. Kress, E. May, R. Cassingena, P. May, Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum, J. Virol. 31 (1979) 472-483.
17. J. Bartek, B. Vojtesek, D.P. Lane, Diversity of human p53 mutants revealed by complex formation to SV40 T antigen, Eur. J. Cancer 29A (1992) 101-107.
18. C. Kuhn, F. Muller, C. Melle, H.P. Nasheuer, F. Janus, W. Deppert, F. Grosse, Surface plasmon resonance measurements reveal stable complex formation between p53 and DNA polymerase alpha, Oncogene 18 (1999) 769-774.
19. G. Mathis, Rare earth cryptates and homogeneous fluoroimmunoassays with human sera, Clin. Chem. 39 (1993) 1953-1959.
20. T. Takahashi, D. Carbone, T. Takahashi, M.M. Nau, T. Hida, I. Linnoila, R. Ueda, J.D. Minna, Wild-type but not mutant p53 suppresses the growth of human lung cancer cells bearing multiple genetic lesions, Cancer Res. 52 (1992) 2340-2343.
21. E. Harlow, L.V. Crawford, D.C. Pim, N.M. Williamson, Monoclonal antibodies specific for simian virus 40 tumor antigens, J. Virol. 39 (1981) 861-869.
22. E.G. Gurney, R.O. Harrison, J. Fenno, Monoclonal antibodies against simian virus 40 T antigens: evidence for distinct sublcasses of large T antigen and for similarities among nonviral T antigens, J. Virol. 34 (1980) 752-763.
23. B. Vojtesek, J. Bartek, C.A. Midgley, D.P. Lane, An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53, J. Immunol. Methods 151 (1992) 237-244.
24. D.R. O'Reilly, L.K. Miller, Expression and complex formation of Simian virus 40 large T and mouse p53 in insect cell, J. Virol. 62 (1988) 3109-3119.
25. C. Delphin, P. Cahen, J.J. Lawrence, J. Baudier, Characterization of baculovirus recombinant wild-type p53 - Dimerization of p53 is required for high-affinity DNA binding and cysteine oxidation inhibits p53 DNA binding, Eur. J. Biochem. 223 (1994) 683-692.
26. R.E. Lanford, Expression of Simian Virus 40 T antigen in insect cells using a baculovirus expression vector, Virology 167 (1988) 72-81.
27. V. Simanis, D. Lane, An immunoaflinity purification procedure for SV40 Large T antigen, Virology 144 (1985) 88-100.
28. E. Lopez, C. Chypre, B. Alpha, G. Mathis, Europium(III) trisbipyridine cryptate label for time resolved fluorescence detection of polymerase chain reaction products fixed on solid support, Clin. Chem. 39 (1993) 196-201.
29. E. Trinquet, F. Maurin, M. Preaudat, G. Mathis, Allophycocyanin 1 as a near-infrared fluorescent tracer: isolation, characterization, chemical modification, and use in a homogeneous fluorescence resonance energy transfer system, Anal. Biochem. 296 (2001) 232-244.
30. F. Omilli, M. Ernoult-Lange, J. Borde, E. May, Sequences involved in initiation of simian virus 40 late transcription in the absence of T antigen, Mol. Cell. Biol. 6 (1986) 1875-1885.
31. G. Mathis, F. Socquet, M. Viguier, B. Darbouret, Homogeneous immunoassays using rare earth cryptates and time resolved fluorescence: Principles and specific advantages for tumor markers, Anticancer Res. 17 (1997) 3011-3014.
32. G. Mathis, Probing molecular interaction with homogeneous techniques based on rare earth cryptates and fluorescence energy transfer, Clin. Chem. 41 (1995) 1391-1397.
33. H. Bazin, M. Preaudat, E. Trinquet, G. Mathis, Homogeneous time resolved fluorescence resonance energy transfer using rare earth cryptates as a tool for probing molecular interactions in biology, Spectrochim. Acta A Mol. Biomol. Spectrosc. 57 (2001) 2197-2211.
34. M.N. Kronick, The use of phycobiliproteins as fluorescent labels in immunoassay, J. Immunol. Methods 92 (1986) 1-13.
35. N. Yabuki, S. Watanabe, T. Kudoh, S. Nihira, C. Miyamoto, Application of homogeneous time-resolved fluorescence (HTRF (TM)) to monitor poly-ubiquitination of wild-type p53, Combinat. Chemi. High Throughput Screening 2 (1999) 279-287.
36. S.A. Kane, C.A. Fleener, Y.S. Zhang, L.J. Davis, A.L. Musselman, P.S. Huang, Development of a binding assay for p53/HDM2 by using homogeneous time-resolved fluorescence, Anal. Biochem. 278 (2000) 29-38.